Streptococcal infection

Related records

Broader conditions (7)

• Bacterial infectious disease
• Disease
• Disease by etiologic mechanism
• Disease of primarily extrinsic mechanism
• Gram-positive bacterial infections
• Human disease
• Infectious disease

Narrower conditions (13)

• Ecthyma
• Erysipelas
• Group B streptococcal infection
• Impetigo
• Impetigo herpetiformis
• Pneumococcal infection
• Pneumococcal meningitis
• Scarlet fever
• Streptococcal meningitis
• Streptococcal pneumonia
• Streptococcal sore throat
• Streptococcal toxic-shock syndrome
• Streptococcus pneumoniae discitis

Trials (142)

• A Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of VAX-A1 in Healthy Young Adults
• A Clinical Trial of the 13-Valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/Tetanus Toxoid)
• A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
• A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority Study
• A Phase 1/2, Randomized, Placebo-controlled, Observer-blinded Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Adults 18 To 49 Years Of Age
• A Phase 2 Study to Evaluate the Safety, Tolerability, and Immune Response of AFX3772 Vaccine in Healthy Infants
• A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
• A Strep Throat Controlled Human Infection Trial in Healthy Adults
• A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients
• A Study for Patients With Complicated Skin and Skin Structure Infections
• A Study in Children With Different Formulations of GSK Biologicals' 11 Valent Pneumococcal Conjugate Vaccine
• A Study in Elderly Subjects With Pneumonia to Support the Development of Bacteriological Diagnostic Assays
• A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants
• A Study to Evaluate Safety, Reactogenicity, and Immunogenicity of the GSK 4-component Strep A Vaccine With Aluminum Hydroxide (Alum) or AS37 in Healthy Young Adults
• A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)
• A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals.
• A TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A BOOSTER DOSE OF A GROUP B STREPTOCOCCUS 6 VALENT POLYSACCHARIDE CONJUGATE VACCINE (GBS6) IN HEALTHY ADULTS
• Amoxicillin for the Treatment of Pediatric Autoimmune Disorders Associated With Streptococcal Infections
• An Assessment of Rapid Streptococcal Tests in Community Clinics in Israel
• Antimicrobial Stewardship Program (ASP) in Patients With a Sore Throat

Approved drugs (1)

• Ertapenem sodium

Drugs in development (9)

• Acetaminophen Phase 3
• Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen Phase 3
• Hepatitis B virus hbsag surface protein antigen Phase 3
• Hepatitis B virus vaccine inactivated Phase 3
• Pertussis vaccine Phase 2
• Sodium chloride Phase 1
• Streptococcus pneumoniae polysaccharide conjugated to corynebacterium diphtheriae toxoid Phase 3
• Streptococcus pneumoniae polysaccharide conjugated to haemophilus influenzae protein D Phase 3
• Streptococcus pneumoniae polysaccharide conjugated to tetanus toxoid Phase 3